https://www.selleckchem.com/products/SGI-1776.html
There was no association between coffee consumption and NAFLD incidence (RR 0.88, 95% CI 0.63-1.25, 0.48) or NAFLD prevalence (RR 0.88, 95% CI 0.76-1.02, = 0.09). The meta-analysis showed coffee consumption to be significantly associated with a 35% decreased odds of significant liver fibrosis (RR 0.65, 95% CI 0.54-0.78, 0.00001). There was no heterogeneity ( = 11%, = 0.34) and no evidence of publication bias ( = 0.134). This meta-analysis supports the protective role of coffee consumption on significant liver fibrosis in patients with